Protocol · Cardiometabolic

Omega-3 (EPA+DHA) 2g

Triglyceride-lowering dose.

Consensus64%leaning supportive
EvidenceMeta-analysis58/100 quality
RiskLowminimal harms
Cost$$monthly
EffortLowtime & habit

Where experts stand

2 tracked voices · updated this week
← opposescautioussupports →
Advocates1 voice
Skeptics1 voice

What the evidence says

Across 2 ledger entries below — what we're weighing, in order of strength.

RCTVITAL: Vitamin D and omega-3 supplementation for primary preventionNEJM · 2019
90/100
MechanisticPlausible mechanism (lipids)Various reviews
43/100

Follow the money

Financial interests don't invalidate arguments — but you should know.

No significant disclosed conflicts among the tracked voices on this protocol.

Discussion

Native comments, Twitter mentions, and Reddit threads about this protocol — surfaced together so the conversation isn't fragmented across platforms.

EL

Posting publicly as Ellen · linked to your social profiles

Sort by:
KP
K. PatelPA · primary care
2d

I've been recommending this to patients for 6 months now. The big shift is patients actually do it because the explanation is concrete.

LS
L. SunRD
1d

Same in nutrition counseling. The before/after framing helps.

MD
M. Danielslifter, 47
5d

Tracking with a CGM on top of this for 3 months. Variability dropped quickly and stayed dropped.

Our synthesis · updated this month
Whalespan view: Omega-3 (EPA+DHA) 2g is reasonable for the right person. The case is real but not airtight — the question is whether your situation puts you in the population the data supports.
How we reach this